Algert Global LLC G1 Therapeutics, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $33,185 - $110,519	-29,630 Reduced 43.51%	38,470 $117,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $83,082 - $181,827	68,100 New	68,100 $98,000
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $329,624 - $611,062	-18,750 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.99 - $20.4 $82,864 - $153,816	7,540 Added 67.26%	18,750 $337,000
Q3 2020 Nov 16, 2020	SELL	$11.55 - $23.75 $50,727 - $104,310	-4,392 Reduced 28.15%	11,210 $129,000
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $26,039 - $66,310	2,721 Added 21.12%	15,602 $379,000
Q1 2020 May 13, 2020	BUY	$9.07 - $26.32 $116,830 - $339,027	12,881 New	12,881 $142,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.